A

Actinium Pharmaceuticals Inc
F:7AY1

Watchlist Manager
Actinium Pharmaceuticals Inc
F:7AY1
Watchlist
Price: 1.364 EUR -4.35% Market Closed
Market Cap: 40.6m EUR

Wall Street
Price Targets

7AY1 Price Targets Summary
Actinium Pharmaceuticals Inc

Wall Street analysts forecast 7AY1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 7AY1 is 4.397 EUR with a low forecast of 1.741 EUR and a high forecast of 8.147 EUR.

Lowest
Price Target
1.741 EUR
28% Upside
Average
Price Target
4.397 EUR
222% Upside
Highest
Price Target
8.147 EUR
497% Upside
Actinium Pharmaceuticals Inc Competitors:
Price Targets
RLYB
Rallybio Corp
39% Upside
PRTA
Prothena Corporation PLC
114% Upside
RIGL
Rigel Pharmaceuticals Inc
4% Upside
IMMU
Mendus AB (publ)
227% Upside
CCCC
C4 Therapeutics Inc
446% Upside
CMPX
Compass Therapeutics Inc.
144% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
61% Upside
MRNA
Moderna Inc
15% Upside

Revenue
Forecast

Revenue Estimate
Actinium Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Actinium Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Actinium Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 7AY1's stock price target?
Price Target
4.397 EUR

According to Wall Street analysts, the average 1-year price target for 7AY1 is 4.397 EUR with a low forecast of 1.741 EUR and a high forecast of 8.147 EUR.

Back to Top